UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma

Clinical cancer research, 2014-10, Vol.20 (19), p.5097-5112

2014

Volltextzugriff (PDF)

Current therapeutic strategies and novel approaches in osteosarcoma

Cancers, 2013-05, Vol.5 (2), p.591-616

2013

Volltextzugriff (PDF)

Osteoprotegerin: Multiple partners for multiple functions

Cytokine & growth factor reviews, 2013-10, Vol.24 (5), p.401-409

2013

Volltextzugriff (PDF)

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma : Blockade of the vicious cycle between tumor cell proliferation and bone resorption

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (15), p.7308-7318

2007

Volltextzugriff (PDF)

12b80 – Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma

Bioconjugate chemistry, 2019-06, Vol.30 (6), p.1665-1676

2019

Volltextzugriff (PDF)

Epinephrine Infiltration of Adipose Tissue Impacts MCF7 Breast Cancer Cells and Total Lipid Content

International journal of molecular sciences, 2019-11, Vol.20 (22), p.5626

2019

Volltextzugriff (PDF)

TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models

International journal of cancer, 2016-12, Vol.139 (12), p.2802-2811

2016

Volltextzugriff (PDF)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

Frontiers in oncology, 2015-12, Vol.5, p.279-279

2015

Volltextzugriff (PDF)

Mifamurtide for the treatment of nonmetastatic osteosarcoma

Expert opinion on pharmacotherapy, 2011-02, Vol.12 (2), p.285-292

2011

Volltextzugriff (PDF)

Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models

PloS one, 2014-03, Vol.9 (3), p.e90795

2014

Volltextzugriff (PDF)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

Oncotarget, 2015-06, Vol.6 (16), p.14413-14427

2015

Volltextzugriff (PDF)

Oncostatin M Is a Growth Factor for Ewing Sarcoma

The American journal of pathology, 2012-11, Vol.181 (5), p.1782-1795

2012

Volltextzugriff (PDF)

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

International journal of cancer, 2015-02, Vol.136 (4), p.784-796

2015

Volltextzugriff (PDF)

In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models

Cytotherapy (Oxford, England), 2018-08, Vol.20 (8), p.1037-1045

2018

Volltextzugriff (PDF)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

Frontiers in oncology, 2018-04, Vol.8, p.133-133

2018

Volltextzugriff (PDF)

Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis

Cancer research (Chicago, Ill.), 2022-03, Vol.82 (6), p.974-985

2022

Volltextzugriff (PDF)

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas

Cancers, 2022-03, Vol.14 (6), p.1482

2022

Volltextzugriff (PDF)

Severe Compromise of Preosteoblasts in a Surgical Mouse Model of Bisphosphonate-Associated Osteonecrosis of the Jaw

Journal of cranio-maxillo-facial surgery, 2016-09, Vol.44 (9), p.1387-1394

2016

Volltextzugriff (PDF)

Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

Journal of bone and mineral research, 2011-10, Vol.26 (10), p.2439-2451

2011

Volltextzugriff (PDF)

TRAIL-based therapy in pediatric bone tumors: how to overcome resistance

Future oncology (London, England), 2015-02, Vol.11 (3), p.535-542

2015

Volltextzugriff (PDF)

Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7610-7619

2010

Volltextzugriff (PDF)

Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma‐bearing mice

Cancer, 2005-12, Vol.104 (11), p.2522-2529

2005

Volltextzugriff (PDF)

The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem

Cells (Basel, Switzerland), 2020-04, Vol.9 (4), p.976

2020

Volltextzugriff (PDF)

A One-Pot Synthesis of 1-Hydroxy-1,1-bis(phosphonic acid)s Starting from the Corresponding Carboxylic Acids

European Journal of Organic Chemistry, 2011-12, Vol.2011 (35), p.7148-7154

2011

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(145)
Life Sciences
(98)
Animals
(93)
Humans
(91)
Oncology
(65)
Cancer
(59)
Osteosarcoma
(58)
Mice
(55)
Human Health And Pathology
(47)
Male
(39)
Biochemistry & Molecular Biology
(37)
Tumors
(37)
Rhumatology And Musculoskeletal System
(36)
Cell Line, Tumor
(33)
Biological And Medical Sciences
(32)
Bone Neoplasms - Pathology
(31)
Bone Neoplasms - Drug Therapy
(29)
Osteosarcoma - Pathology
(28)
Female
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma

Current therapeutic strategies and novel approaches in osteosarcoma

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

Osteoprotegerin: Multiple partners for multiple functions

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma : Blockade of the vicious cycle between tumor cell proliferation and bone resorption

12b80 – Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma

Epinephrine Infiltration of Adipose Tissue Impacts MCF7 Breast Cancer Cells and Total Lipid Content

TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

Mifamurtide for the treatment of nonmetastatic osteosarcoma

Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

Oncostatin M Is a Growth Factor for Ewing Sarcoma

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas

Severe Compromise of Preosteoblasts in a Surgical Mouse Model of Bisphosphonate-Associated Osteonecrosis of the Jaw

Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

TRAIL-based therapy in pediatric bone tumors: how to overcome resistance

Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma‐bearing mice

The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem

A One-Pot Synthesis of 1-Hydroxy-1,1-bis(phosphonic acid)s Starting from the Corresponding Carboxylic Acids

Suchergebnisse filtern